5-Alpha reductase inhibitors in prostate cancer: From clinical trials to clinical practice Journal Article


Authors: Ehdaie, B.; Touijer, K. A.
Article Title: 5-Alpha reductase inhibitors in prostate cancer: From clinical trials to clinical practice
Keywords: cancer survival; controlled study; cancer surgery; major clinical study; placebo; cancer growth; cancer risk; drug efficacy; treatment duration; bone metastasis; cancer radiotherapy; cancer staging; editorial; tumor biopsy; risk factor; cancer mortality; cancer hormone therapy; prostate-specific antigen; prostatic neoplasms; prostatectomy; dutasteride; antineoplastic agents, hormonal; kallikreins; castration resistant prostate cancer; reduction; randomized controlled trial (topic); 5-alpha reductase inhibitors; azasteroids
Journal Title: European Urology
Volume: 63
Issue: 5
ISSN: 0302-2838
Publisher: Elsevier Science, Inc.  
Date Published: 2013-05-01
Start Page: 788
End Page: 789
Language: English
PROVIDER: scopus
PUBMED: 23305882
DOI: 10.1016/j.eururo.2012.12.035
DOI/URL:
Notes: --- - Cited By (since 1996):1 - "Export Date: 1 May 2013" - "CODEN: EUURA" - ":doi 10.1016/j.eururo.2012.12.035" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Karim Abdelkrim Touijer
    259 Touijer
  2. Behfar Ehdaie
    174 Ehdaie